NMD4C Early Career Award Nominations Extended

We have extended the nomination submission deadline for our NMD4C Early-Career Investigator Awards! The new deadline is January 13th, 2023.

This initiative will allow NMD4C early-career members to be nominated for one of four awards, celebrating excellence and contribution to the neuromuscular field in both clinical and basic science streams.

The four early-career award categories that will be awarded for 2022 are:

  • Early Career Researcher of the Year (Biomedical)
  • Early Career Researcher of the Year (Clinical)
  • Publication of the Year (Biomedical)
  • Publication of the Year (Clinical)

If you wish to nominate yourself or an individual for any of these awards, please submit the following information via the nomination form here: https://www.surveymonkey.ca/r/NMD4C-ECawards.

You will be asked to include:

  1. Category for which you are nominating the individual.
  2. Brief bio sketch of the nominee. (any kind of biosketch accepted)
  3. Up to three clinical or research milestones of the nominee.
  4. Brief paragraph highlighting the achievements of the individual, and why you think they should receive the award.
  5. (For publication of the year biomedical/clinical) A PDF copy of the full publication you wish to nominate. *Publications from November 2021 – Present will be eligible.

Please complete this nomination form before the deadline of January 13, 2023 at 11:59pm ET.

The awards will be announced in January 2023 alongside the NMD4C/MDC neuromuscular clinical and postdoctoral research fellowships. If you have any questions, please feel free to reach out to communications coordinator James Davis at !

To be eligible for this award you must fall within the CIHR early-career criteria as being within five years of the date of a first independent appointment, and be a member of the NMD4C (if you are not a member, you can sign up here!)

NMD4C launches early career awards for 2022.

Read next...

2025 clinical and research fellowships competition from NMD4C and MDC.

Fourth Annual Clinical & Postdoctoral Fellowship Competition from NMD4C, MDC to Open Fall 2024

NMD4C together with Muscular Dystrophy Canada are excited to announce that our annual Neuromuscular Fellowship Competition will open again for a fourth year on September 3, 2024!

NMD4C wraps up 2023-2024 neuromuscular clinical training curriculum

NMD4C Wraps up Second Year of Training Series for Canadian Neuromuscular Clinical Fellows

We’re excited to share that the second annual National Neuromuscular Lecture Series (NNLS) finished last week!

2024 NMD4C basic research summer school. Photo of attendees on the right.

NMD4C Host Inaugural Basic Research Summer School

Over May 27-28 2024, the NMD4C animal and cell-based research team hosted the first-ever annual basic research summer school for neuromuscular research trainees at McGill University in Montréal, QC. 

NMD4C investigator Dr Reshma Amin receives funding from CIHR for a grant to develop a framework for real-world evidence for NMDs in Canada

NMD4C Investigator Dr. Reshma Amin Leads Successful CIHR Grant Application to Establish a Framework for Real-World Evidence for Canadian Neuromuscular Diseases

Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs   The NMD4C is excited to share that network investigator Dr. Reshma Amin has been awarded funding from the CIHR to establish a framework for real-world evidence (RWE) for Canadian…

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

The NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures. 

Canadian Neuromuscular Community of Practice

NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs

As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.